Clinical Conversation in Interventional Cardiology: Intracardiac Echocardiography to Guide Structural Heart Disease Interventions
Overview

Intracardiac echocardiography (ICE) has been used by physicians for decades to guide catheter-based procedures. However, its application in complex valvular interventions was previously limited due to hardware and software constraints. While transesophageal echocardiography (TEE) remains a staple for guiding transcatheter SHD interventions, several factors are driving a greater role for physician-led intraprocedural ICE imaging. Distorted cardiac anatomy, intracardiac shadowing, and the esophagus's position relative to cardiac structures can restrict TEE imaging windows, necessitating the use of ICE for better visualization.

Review the SCAI Position Statement on Intracardiac Echocardiography to Guide Structural Heart Disease Interventions

Faculty and Agenda

Suzanne J. Baron, MD, FSCAI
Moderator

Mackram F. Eleid, MD, FSCAI
Andrew Michael Goldsweig, MD,  MSc, FSCAI 
Omar Khalique, MD, FSCAI 
Acknowledgement of Commercial Support
This activity is supported by unrestricted educational grants from Abbott, Edwards Lifesciences, and Philips.
Learning Objectives
At the conclusion of this initiative participants will be able to demonstrate the ability to: 
  1. Understand the emerging role of ICE in structural heart disease interventions, including its advantages and limitations compared to TEE.
  2. Identify and use standardized ICE imaging protocols for consistent and comprehensive anatomical visualization.
  3. Implement ICE technology in clinical workflows, considering administrative, financial, and training aspects.
Disclosures
During the development of this activity, the following financial relationships with industry were disclosed:

Planners:
  • Mackram Eleid: No relevant financial relationships with ineligible companies. 
  • Omar Khalique: Abbott - consulting; Philips - consulting; Siemens - consulting. 
Faculty:
  • Suzanne Baron: Abbott - Advisory Board; Boston Scientific - Advisory Board, consulting, PI, speaker; Edwards Lifesciences - consulting, speaker; Medtronic - Advisory Board, speaker.
  • Mackram Eleid: No relevant financial relationships with ineligible companies. 
  • Andrew Goldsweig: Abbott - consulting; Boston Scientific - speaker; Conformal Medical - consulting; Philips - speaker. 
  • Omar Khalique: Abbott - consulting; Philips - consulting; Siemens - consulting. 
Reviewer:
  • Tara Jones: No relevant financial relationships with ineligible companies. 
SCAI Staff:
  • Olivia Demarest, Scott Firestone, Kristen Perry, and Amanda Pettyjohn: No relevant financial relationships with ineligible companies. 
Accredited Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the 
Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

​Credit Designation
SCAI designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

​ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 0.25 MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

Activity Timeline:
Recording date: 9/16/2025
Publish date: 2/17/2026
Expiration date: 2/17/2029

Copyright
© 2026 Society for Cardiovascular Angiography and Interventions (SCAI). All rights reserved.
Summary
Availability:
On-Demand
Expires on Feb 17, 2029
Cost:
FREE
Credit Offered:
0.25 CME Credit
0.25 ABIM-MOC Point
0.25 Participation Credit
Powered By